Amplitude Healthcare Acquisition Corp | Business Contracts

First Amendment to Employment Agreement, dated April 13, 2023, by and between Jasper Therapeutics, Inc. and Ronald Martell (Filed With SEC on April 14, 2023)

Letter Regarding Service Agreement, dated April 13, 2023, by and between Jasper Therapeutics, Inc. and William Lis (Filed With SEC on April 14, 2023)

Jasper Therapeutics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 8, 2023)

Description of Securities of Jasper Therapeutics, Inc (Filed With SEC on March 8, 2023)

Underwriting Agreement, dated as of January 25, 2023, by and between Jasper Therapeutics, Inc., Credit Suisse Securities (USA) LLC, William Blair & Company, L.L.C., and... (Filed With SEC on January 25, 2023)

Controlled Equity OfferingSM Sales Agreement, dated as of November 10, 2022, by and between the Registrant and Cantor Fitzgerald & Co (Filed With SEC on November 10, 2022)

Separation Agreement and General Release of All Claims, dated March 17, 2022, by and between the Registrant and Kevin N. Heller, M.D (Filed With SEC on May 12, 2022)

Description of Securities of Jasper Therapeutics, Inc (Filed With SEC on March 18, 2022)

Jasper Therapeutics, Inc. 2022 Inducement Equity Incentive Plan (Filed With SEC on March 16, 2022)

Service Agreement, dated March 7, 2022, by and between Jasper Therapeutics, Inc. and William Lis (Filed With SEC on March 11, 2022)

Employment Agreement, dated February 25, 2022, between Jasper Therapeutics, Inc. and Ronald Martell (Filed With SEC on February 28, 2022)

Jasper Therapeutics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on October 29, 2021)

Amendment to Sponsor Support Agreement, dated as of September 24, 2021, by and among Amplitude Healthcare Acquisition Corporation, Amplitude Healthcare Holdings LLC and Jasper... (Filed With SEC on September 29, 2021)

Employment Agreement, dated as of September 24, 2021, by and between Jasper Therapeutics, Inc. and Kevin Heller (Filed With SEC on September 29, 2021)

Employment Agreement, dated as of September 24, 2021, by and between Jasper Therapeutics, Inc. and Jeet Mahal (Filed With SEC on September 29, 2021)

Employment Agreement, dated as of September 24, 2021, by and between Jasper Therapeutics, Inc. and William Lis (Filed With SEC on September 29, 2021)

Jasper Therapeutics, Inc., 2021 Employee Stock Purchase Plan (Filed With SEC on September 29, 2021)

Jasper Therapeutics, Inc. 2021 Equity Incentive Plan Form of RSU Award Grant Notice and Award Agreement (RSU Award) (Filed With SEC on September 29, 2021)

Jasper Therapeutics, Inc. 2021 Equity Incentive Plan Form of Stock Option Grant Notice and Stock Option Agreement (Filed With SEC on September 29, 2021)

Jasper Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on September 29, 2021)

Amended and Restated Registration Rights Agreement, dated September 24, 2021, by and among Jasper Therapeutics, Inc. and the stockholders party thereto (Filed With SEC on September 29, 2021)

Description of Securities (Filed With SEC on March 26, 2020)

Letter Agreement, dated January 6, 2020, by and between the Company and Vishal Kapoor (Filed With SEC on January 8, 2020)

Employment Agreement, dated January 6, 2020, by and between the Company and Vishal Kapoor (Filed With SEC on January 8, 2020)

Warrant Agreement, dated November 19, 2019, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on November 25, 2019)

Underwriting Agreement, dated November 19, 2019, by and among the Company, BMO Capital Markets Corp. and SVB Leerink LLC (Filed With SEC on November 25, 2019)

Letter Agreement, dated November 19, 2019, by and among the Company, its officers, directors and the Sponsor (Filed With SEC on November 25, 2019)

Investment Management Trust Agreement, dated November 19, 2019, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on November 25, 2019)

Registration Rights Agreement, dated November 19, 2019, by and between the Company and the Sponsor (Filed With SEC on November 25, 2019)

Private Placement Warrants Purchase Agreement, dated November 19, 2019, by and between the Company and the Sponsor (Filed With SEC on November 25, 2019)

Form of Warrant Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on November 14, 2019)

Form of Registration Rights Agreement among the Registrant and certain security holders (Filed With SEC on November 6, 2019)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on November 6, 2019)

Form of Letter Agreement among the Registrant and its officers and directors and Amplitude Healthcare Holdings LLC (Filed With SEC on November 6, 2019)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on November 6, 2019)

Specimen Warrant Certificate (Filed With SEC on November 6, 2019)

Specimen Class A Common Stock Certificate (Filed With SEC on November 6, 2019)

Specimen Unit Certificate (Filed With SEC on November 6, 2019)

Form of Underwriting Agreement (Filed With SEC on November 6, 2019)

Form of Private Placement Warrants Purchase Agreement between the Registrant and Amplitude Healthcare Holdings LLC (Filed With SEC on November 6, 2019)

Form of Indemnity Agreement (Filed With SEC on November 6, 2019)

Promissory Note, dated August 23, 2019, issued to Amplitude Healthcare Holdings LLC (Filed With SEC on October 25, 2019)

Securities Subscription Agreement, dated August 23, 2019, between the Registrant and Amplitude Healthcare Holdings LLC (Filed With SEC on October 25, 2019)

Amplitude Healthcare Acquisition Corp (43)